All the three subunits RPA1, RPA2, and RPA3, were more abundant (with statistical significance evidence) in lymph node negative and earlier stage (stage I and II) gastric carcinomas (Fourtziala et al., 2020). This evidence concerns the gene RPA2 and gastric carcinoma.